Edition:
United States

Catalyst Pharmaceuticals Inc (CPRX.OQ)

CPRX.OQ on NASDAQ Stock Exchange Capital Market

2.51USD
20 Apr 2018
Change (% chg)

$-0.03 (-1.18%)
Prev Close
$2.54
Open
$2.52
Day's High
$2.56
Day's Low
$2.46
Volume
105,296
Avg. Vol
181,970
52-wk High
$4.51
52-wk Low
$1.62

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.059
Sep '17 0.00 -0.049
Jun '17 0.00 -0.046
Mar '17 0.00 -0.060
FY 2016 Dec '16 0.00 -0.050
Sep '16 0.00 -0.048
Jun '16 0.00 -0.055
Mar '16 0.00 -0.065
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 4 0.00 0.00 0.00 --
Quarter Ending Sep-18 4 0.00 0.00 0.00 --
Year Ending Dec-18 4 1.46 3.55 0.00 12.97
Year Ending Dec-19 4 25.43 43.71 14.22 48.52
Earnings (per share)
Quarter Ending Jun-18 4 -0.07 -0.05 -0.09 -0.06
Quarter Ending Sep-18 4 -0.08 -0.06 -0.10 -0.06
Year Ending Dec-18 4 -0.36 -0.23 -0.58 -0.23
Year Ending Dec-19 4 -0.11 -0.01 -0.23 -0.02
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 188.22 33.60
P/E High - Last 5 Yrs. -- 284.72 45.95
P/E Low - Last 5 Yrs. -- 95.76 24.93
Beta 1.51 0.75 0.80
Price to Sales (TTM) -- 136.15 7.07
Price to Book (MRQ) 3.18 19.54 5.13
Price to Tangible Book (MRQ) 3.18 24.07 6.73
Price to Cash Flow (TTM) -- 122.99 25.52
% Owned Institutions 55.62 11.18 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.51
Dividend Yield - 5 Year Avg -- 0.20 0.75
Dividend 5 Year Growth Rate -- 1.94 3.93
Payout Ratio(TTM) -- 9.18 20.35

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 103.73 9.02
Sales (TTM) vs TTM 1 Yr. Ago -- 79.72 10.83
Sales - 5 Yr. Growth Rate -- 33.87 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -17.22 -66.87 22.25
EPS (TTM) vs TTM 1 Yr. Ago 1.75 -- --
EPS - 5 Yr. Growth Rate -- 47.46 10.26
Capital Spending - 5 Yr. Growth Rate -- 45.48 10.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.53
Current Ratio (MRQ) 19.97 5.97 3.62
LT Debt to Equity (MRQ) 0.00 23.32 11.31
Total Debt to Equity (MRQ) 0.00 25.75 13.97
Interest Coverage (TTM) -- -186.61 30.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 36.56 54.01
Gross Margin - 5 Yr. Avg. -- 55.38 52.12
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -152.18 15.89
Operating Margin (TTM) -- -563.03 4.33
Operating Margin - 5 Yr. Avg. -- -164.18 11.25
Pre-Tax Margin (TTM) -- -535.84 4.97
Pre-Tax Margin - 5 Yr. Avg. -- -171.12 11.56
Net Profit Margin (TTM) -- -524.81 1.58
Net Profit Margin - 5 Yr. Avg. -- -171.01 7.89
Effective Tax Rate (TTM) -- -0.44 31.30
Effective Tax Rate - 5 Yr. Avg. -- 18.14 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,887,722 816,988,634
Net Income/Employee (TTM) -876,780 956,935 96,050,323
Receivable Turnover (TTM) -- 6.24 5.56
Inventory Turnover (TTM) -- 2.37 3.45
Asset Turnover (TTM) 0.00 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -28.97 -0.77 10.54
Return on Assets - 5 Yr. Avg. -37.98 0.70 11.56
Return on Investment (TTM) -30.50 -0.74 13.19
Return on Investment - 5 Yr. Avg. -41.02 4.20 14.97
Return on Equity (TTM) -30.62 -2.80 15.00
Return on Equity - 5 Yr. Avg. -42.36 -0.05 16.25
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 1.60 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Catalyst Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 55.67%
# of Holders: 129
Total Shares Held: 57,091,537
3 Mo. Net Change: 293,393
# New Positions: 3
# Closed Positions: 3
# Increased Positions: 8
# Reduced Positions: 7
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.